Filing Details
- Accession Number:
- 0001209191-22-005556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-31 16:00:12
- Reporting Period:
- 2022-01-27
- Accepted Time:
- 2022-01-31 16:00:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1260990 | Oncternal Therapeutics Inc. | ONCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244823 | B James Breitmeyer | 12230 El Camino Real, Suite 300 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-27 | 25,000 | $1.68 | 46,544 | No | 4 | P | Indirect | By Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Family Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 384,149 | Direct | |
| Common Stock | 6,493 | Indirect | By Spouse |
| Common Stock | 733 | Indirect | By Child |
Footnotes
- The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.85. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
- This Form 4 corrects the number of RSUs awarded on January 3, 2022 held by the Reporting Person's spouse erroneously reported as 6,793 due to clerical error.
Billionaire Hedge Funds
